DAFNA Capital Management LLC - PROTEOSTASIS THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 62 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q4 2018$177,000
-86.1%
54,569
-79.6%
0.09%
-85.7%
Q1 2018$1,269,000
+85.3%
267,100
+127.3%
0.62%
+67.2%
Q4 2017$685,000–117,500–0.37%–
 Download
Other shareholders

There were no reported owners of PROTEOSTASIS THERAPEUTICS IN in Q2 2018.

NameSharesValueWeighting ↓
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders